Inflammation Research

Papers
(The H4-Index of Inflammation Research is 33. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
News335
Unveiling the role of ABI3 and hub senescence-related genes in macrophage senescence for atherosclerotic plaque progression221
Inhibition of glycolytic reprogramming suppresses innate immune-mediated inflammation in experimental amyotrophic lateral sclerosis171
Paradoxical expression of NRP1 in decidual stromal and immune cells reveals a novel inflammation balancing mechanism during early pregnancy114
Kinin B1 receptor and TLR4 interaction in inflammatory response96
Loss of TRIM24 promotes IL-10 expression via CBP/p300-dependent IFNβ1 transcription during macrophage activation92
Immunity-related GTPase IRGM at the intersection of autophagy, inflammation, and tumorigenesis89
Beyond CYP2C19: inflammation and angiogenesis gene variants drive clopidogrel resistance in CAD patients76
Long-chain acyl-CoA synthetase 4-mediated mitochondrial fatty acid metabolism and dendritic cell antigen presentation68
Serum from COVID-19 patients promotes endothelial cell dysfunction through protease-activated receptor 268
Viperin inhibits interferon-γ production to promote Mycobacterium tuberculosis survival by disrupting TBK1-IKKε-IRF3-axis and JAK-STAT signaling60
Association of risk of incident acne and treatment with systemic Janus kinase inhibitors in atopic dermatitis: a systematic review and meta-analysis59
Immune-related genetic single-nucleotide polymorphisms contribute to prognosis and response to chemotherapy in patients with acute lymphoblastic leukemia59
CD20+ T cells: an emerging T cell subset in human pathology57
Tissue-resident immune cells in the pathogenesis of multiple sclerosis56
Single-cell hdWGCNA reveals a novel diagnostic model and signature genes of macrophages associated with chronic obstructive pulmonary disease50
The NADase CD38 is a central regulator in gouty inflammation and a novel druggable therapeutic target50
From bench to bedside: targeting lymphocyte activation gene 3 as a therapeutic strategy for autoimmune diseases47
The role of fatty acid metabolism on B cells and B cell-related autoimmune diseases46
IL10/AMPK pathway was associated with the hippocampal anti-inflammatory response to high-sugar and high-fat diet withdrawal46
Mitochondrial damage causes inflammation via cGAS-STING signaling in ketamine-induced cystitis45
HMGB1: key mediator in digestive system diseases44
IL-33, a neutrophil extracellular trap-related gene involved in the progression of diabetic kidney disease44
Clinical outcomes of anti-inflammatory therapies inhibiting the NLRP3/IL-1β/IL-6/CRP pathway in coronary artery disease patients: a systemic review and meta-analysis of 37,056 individuals from 32 rand44
Viperin deficiency promotes dendritic cell activation and function via NF-kappaB activation during Mycobacterium tuberculosis infection41
The role of dietary fibre in lung inflammation: microbiota, metabolites, and immune crosstalk40
A suitable model to investigate acute neurological consequences of coronavirus infection39
IL-1 receptor antagonist: etiological and drug delivery systems overview39
Functional characterization of novel anti-DEFA5 monoclonal antibody clones 1A8 and 4F5 in inflammatory bowel disease colitis tissues38
Mitochondrial proteomics reveals the impact of Estrogen in enhancing energy metabolism of patient-derived fibroblast-like synoviocytes in rheumatoid arthritis37
Navigating the complex landscape of DPP4 inhibition in inflammation: from novel mechanisms to unresolved translational challenges37
Annexin A1 is crucial during Toxoplasma gondii infection promoting the modulation of inflammation and intestinal and central nervous system barrier functions34
Successful treatment of refractory erythrodermic pemphigus foliaceus with low-dose rituximab and intravenous immunoglobulin33
A pain from the nose to the head: neurological commitment during long COVID33
0.096331834793091